Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (141-150 of 373) with videos related to

Pageof 38
Sort By:
Cancers|July 2, 2021
Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial NeoplasiaAllison M Puechl, Daniel Spinosa, Andrew Berchuck, et al.
Journal of the National Cancer Institute|January 5, 2002
Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-betaGustavo C Rodriguez, Nimesh P Nagarsheth, Karen L Lee, et al.
Gynecologic Oncology|August 30, 2024
Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicityClare Meernik, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.
Neoplasia (New York, N.Y.)|September 14, 2024
Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancerPamela N Peters, Regina S Whitaker, Felicia Lim, et al.
The Journal of Pathology|March 3, 2025
Cellular origins of mucinous ovarian carcinomaNicola S Meagher, Martin Köbel, Anthony N Karnezis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancersAndrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2017
Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future DirectionsSiddhartha P Kar, Andrew Berchuck, Simon A Gayther, et al.
Cancer Research|May 20, 2004
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancerMara H Rendi, Nanjoo Suh, William W Lamph, et al.
Cancer Research Communications|March 5, 2024
Health Care Access Dimensions and Racial Disparities in End-of-Life Care Quality among Patients with Ovarian CancerShama Karanth, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.
Gynecologic Oncology|November 13, 2023
High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancerKatherine E Baumann, Sharareh Siamakpour-Reihani, Joseph Dottino, et al.
Pageof 38

Showing results (141-150 of 373) with videos related to

Sort By:
Pageof 38
Cancers|July 2, 2021
Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial NeoplasiaAllison M Puechl, Daniel Spinosa, Andrew Berchuck, et al.
Journal of the National Cancer Institute|January 5, 2002
Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-betaGustavo C Rodriguez, Nimesh P Nagarsheth, Karen L Lee, et al.
Gynecologic Oncology|August 30, 2024
Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicityClare Meernik, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.
Neoplasia (New York, N.Y.)|September 14, 2024
Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancerPamela N Peters, Regina S Whitaker, Felicia Lim, et al.
The Journal of Pathology|March 3, 2025
Cellular origins of mucinous ovarian carcinomaNicola S Meagher, Martin Köbel, Anthony N Karnezis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancersAndrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2017
Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future DirectionsSiddhartha P Kar, Andrew Berchuck, Simon A Gayther, et al.
Cancer Research|May 20, 2004
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancerMara H Rendi, Nanjoo Suh, William W Lamph, et al.
Cancer Research Communications|March 5, 2024
Health Care Access Dimensions and Racial Disparities in End-of-Life Care Quality among Patients with Ovarian CancerShama Karanth, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.
Gynecologic Oncology|November 13, 2023
High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancerKatherine E Baumann, Sharareh Siamakpour-Reihani, Joseph Dottino, et al.
Pageof 38